Althea Group Holdings

Althea Group Holdings Althea Group Holdings Ltd (ASX:AGH) is a global leader in the manufacturing, sales and distribution of cannabis-based medicines and consumer packaged goods.

Althea Group Holdings Ltd (‘AGH’) is a global leader in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products. AGH provides high-quality pharmaceutical and recreational cannabis products, delivered by two distinct business verticals: Althea who supply to the global cannabis-based medicines market and Peak Processing Solutions, who supply to the legal cannabis market in Canada. Founded in Australia, AGH now have operations across 4 continents in highly regulated and legal cannabis markets, operating in Europe, North America, Australia and Africa.

Address

360 Elizabeth Street
Pyalong, VIC
3000

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Althea Group Holdings posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Althea Group Holdings:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Althea Company Pty Ltd aims to improve the quality of life of Australians suffering from debilitating conditions by providing education and patient access to high quality medicinal cannabis products.

Althea Company was founded in Melbourne in 2017 with a view to acquiring the necessary licences and permits to import, cultivate, produce and supply medicinal cannabis for eligible patients across Australia. In May 2018, Althea commenced sales of five Althea branded medicinal cannabis products to eligible patients across Australia.

Althea’s team of medical science liaisons across the country help educate health care professionals about medicinal cannabis and provide clarity and support to navigate the complexities of regulation and patient access.